Ethical considerations in deep brain stimulation for psychiatric illness
Ryan A Grant1, Casey H Halpern2, Gordon H Baltuch2
1Department of Neurosurgery, Yale, New Haven Medical Center, 60 Temple Street, New Haven, CT 06510, USA.
Summary
Deep brain stimulation (DBS) offers therapeutic potential for psychiatric disorders but requires careful ethical consideration. This review addresses key ethical challenges in DBS research, including patient selection and informed consent.
Area of Science:
- Neuroscience
- Psychiatry
- Bioethics
Background:
- Deep brain stimulation (DBS) is an effective surgical treatment for psychiatric conditions like obsessive-compulsive disorder and treatment-resistant depression.
- DBS research offers insights into mood, cognition, and behavior, but raises significant ethical questions.
Purpose of the Study:
- To review and address critical ethical considerations in the design and implementation of deep brain stimulation clinical research trials.
- To ensure ethical boundaries are maintained for the proper evaluation of DBS's therapeutic potential in psychiatric disorders.
Main Methods:
- Literature review focusing on ethical aspects of DBS research.
- Discussion of specific ethical issues including patient selection, informed consent, pediatric use, identity alteration, enhancement, and resource allocation.
Main Results:
- Ethical challenges in DBS research are multifaceted, spanning patient rights, trial design, and societal implications.
- Key areas requiring careful ethical navigation include informed consent, pediatric applications, and the potential for cognitive or behavioral modification.
Conclusions:
- Rigorous ethical frameworks are essential for advancing DBS research responsibly.
- Addressing these ethical concerns is crucial for harnessing the therapeutic potential of DBS while protecting participants.
